In-depth coverage of the UK’s exit from the EU, and what it means to pharma and healthcare.
Japanese pharma getting frustrated with NICE
Parallel Trade 2018
Government must strike science R&D deal with EU, says ABPI
But BMA warns more must be done to prevent Brexit brain-drain.
Europe’s medicines regulator will move from London after Brexit
Health and business secretaries commit to close working with EMA